PERSONALISED CHEMOTHERAPY IN THE 21ST CENTURY
By Wendy M. Wong, Oncology Specialist, Dept. of Pharmaceutical Services, UCI Medical Center, USA
HISTORY Cancer is associated with high morbidity and mortality. In the United States, cancer accounts for nearly one quarter of all deaths, surpassed only by heart disease. Globally, oncologic disease is a burden as
well.Cancer incidence is expected to increase as people live longer and become more exposed to a variety of agents such
10
www.lifesciencesmagazines.com
as tobacco, environmental toxins, and viruses. In addition, as countries prosper, their populations adopt a less healthy lifestyle, becoming more obese. According to the World Health Organization, the projected number of deaths worldwide from malignant neoplasms is expected to grow from 7.4 million in 2004 to 11.9 million in 2030.
“Personalised chemotherapy is still in its infancy with small target populations and rare complete responses”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40